Taking aspirin reduces the risk of pre-eclampsia by 15 percent, premature birth by 20 percent, and intrauterine growth restriction by 18 percent.
Pregnant women at risk include those with previous pre-eclampsia, carrying multiples, kidney disease, diabetes, hypertension, or aged over 35 with a BMI >30.
Pre-eclampsia is a leading cause of maternal mortality in the US, disproportionately affecting Black women, highlighting the need for wider awareness and adherence to aspirin recommendations.
[
add
]
[
|
|
...
]